AzTrials
AzTrials

Pain, PostoperativeNCT07650877

Comparison of the Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block

A study testing Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block in people with Pain, Postoperative and Multimodal Analgesia, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Video-assisted thoracic surgery (VATS) is widely performed for the management of various thoracic pathologies and is generally associated with reduced surgical trauma compared with open thoracotomy. Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Jun 2026to 30 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing elective VATS
  • Patients aged 18-75 years
  • Patients with ASA (American Society of Anesthesiologists) class I-III
  • Patients who have given informed consent

Who cannot join

  • Patients allergic to local anesthetics
  • Patients with bleeding disorders or those undergoing anticoagulant therapy
  • Pregnant and breastfeeding women
  • Patients with impaired consciousness, inability to communicate, or mental/cognitive impairment
  • Patients who refuse block application
  • Patients with infection in the area where the block will be applied

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Emine Nilgün Zengin, Associate Professor contact

00905063370548

nilbavullu@gmail.com

Hülya Yiğit, Associate Professor contact

00905054853939

yigitozay@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Ankara City Hospital

    Çankaya, Ankara, 06290

    Emine N Zengin, MD, +905063370548, nilbavullu@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effects of Ultrasound-Guided Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block on Postoperative Acute Pain in Patients Undergoing Video-Assisted Thoracoscopic Surgery

Video-assisted thoracic surgery (VATS) is widely performed for the management of various thoracic pathologies and is generally associated with reduced surgical trauma compared with open thoracotomy. Nevertheless, patients may still experience considerable postoperative pain, which can adversely affect respiratory function, mobilization, and recovery. Various regional analgesic techniques have been incorporated into multimodal pain management strategies for VATS, including thoracic paravertebral block (TPVB), erector spinae plane block (ESPB), intercostal nerve block, serratus anterior plane block (SAPB), rhomboid intercostal block (RIB), and serratus posterior superior intercostal plane block (SPSIPB). Among these approaches, ultrasound-guided TPVB has traditionally been regarded as a reference regional analgesic technique. More recently, interfascial plane blocks have gained increasing attention because of their technical simplicity and favorable safety profile. RIB and SPSIPB are two novel interfascial plane blocks that may provide effective postoperative analgesia following thoracic surgery. The present study aims to compare the analgesic efficacy of RIB and SPSIPB in patients undergoing VATS and to evaluate their impact on postoperative pain outcomes.

Being tested
Rhomboid Intercostal Block, Serratus Posterior Superior Intercostal Plane Block
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rhomboid Intercostal BlockDrug

    Rhomboid intercostal block will be applied to the patients under real-time ultrasound guidance.

  • Serratus Posterior Superior Intercostal Plane BlockDrug

    Serratus posterior superior intercostal plane block will be applied to the patients under real-time ultrasound guidance.

Study groups in NCT07650877
Study groupRoleWhat they receive
Rhomboid Intercostal BlockActive comparatorFor patients scheduled to receive a Rhomboid Intercostal Block (RIB), after sonographic identification of the relevant anatomical structures, the block needle is advanced using an in-plane ultrasound-guided technique beneath the rhomboid muscle until contact with the rib is achieved. Following hydrodissection with 2 mL of normal saline to confirm correct needle placement, 30 mL of 0.25% bupivacaine is injected into the interfascial plane.
Receives: Drug: Rhomboid Intercostal Block
Serratus Posterior Superior Intercostal Plane BlockActive comparatorFor patients scheduled to receive a Serratus Posterior Superior Intercostal Plane Block (SPSIPB), after sonographic identification of the relevant anatomical structures, the block needle is advanced using an in-plane ultrasound-guided technique beneath the serratus posterior superior muscle until contact with the rib is achieved. Following hydrodissection with 2 mL of normal saline to confirm correct needle placement, 30 mL of 0.25% bupivacaine is injected into the interfascial plane.
Receives: Drug: Serratus Posterior Superior Intercostal Plane Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Surgical Pain Scores

    Surgical pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0mm (no pain) to 100mm (worst pain). Pain assessment will be done at 1st, 6th, 12th, and 24th hours after surgery.

    Measured: 24 hours after surgery

Secondary outcomes (2)
  1. Shoulder Pain Scores

    Shoulder pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0mm (no pain) to 100mm (worst pain).

    Pain assessment will be done at 1st, 6th, 12th, and 24th hours after surgery.

    Measured: 24 hours after surgery

  2. Intraoperative remifentanil consumption

    The amount of remifentanil that patients need to maintain anesthesia during the intraoperative period will be recorded.

    Measured: During the intraoperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2026
  2. Study start15 Jun 2026
  3. Primary completion20 Nov 2026 (estimated)
  4. Study completion30 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07650877
Sponsor's protocol ID
E.Kurul-E2-26-14830
Status last verified
Jun 2026
First submitted
11 Jun 2026
Last updated
16 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block in people with Pain, Postoperative and Multimodal Analgesia, run by Ankara City Hospital Bilkent at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emine Nilgün Zengin, Associate Professor (00905063370548, nilbavullu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Surgical Pain Scores (time frame: 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in